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INTRODUCTION 
In a récent lecture, the plant breeder 
Norman Borlaug (1970 Nobel Peace 
Prize Lauréate) underlined that plant 
biotechnology is likely to be instrumen-
tal in dealing with the complexities of 
"feeding a world of 10 billion people" 
(1) that the current populat ion of 
5.8 billion would certainly reach during 
the next century before stabilizing. Ag-
ricultural biotechnology is expected to 
play a particular rôle in the less devel-
oped countries (LDCs) where sti l l 
800 million underfed people are con-
centrated but where spécial constraints 
and challenges are faced with. For ex-
ample, the population in the Third World 
relies to a large extent on staple crops 
as cassava, sweet potato and tropical 
fruits that are hardly known in the de-
veloped countries. As a resuit, high-
quality scientific research is scarce with 
thèse crops. In addition, the tropical 
climate that prevails in most LDCs caus-
es a number of significant conséquenc-
es, e.g. due to the absence of dorman-
cy, (i) many tropical crops propagate 
(exclusively) vegetatively which makes 
classical breeding extremely difficult, 
and (ii) pathogens and pests can per-
manently damage their hosts. 
BANANA: A CASE STORY 
Banana is a very characteristic case to 
describe the dimensions and problems 
biotechnological research will meet in 
the Third World. With more than 85 
million metric tons annually produced 
mainly in backyards and small farms in 
120 countries (2), banana is the No. 1 
fruit crop in the world which is not only 
consumed fresh or as dessert but baked, 
boiled, cooked, fried and even brewed 
to béer or puréed for baby food. Ninety 
percent of banana production is con-
sumed locally and serves as staple food 
for some 400 million people Worldwide 
due to the high starch content. In fact, 
banana is the fourth major food source 
(after rice, milk and wheat) in the devel-
oping world. In addition, the export 
value of the 10% production entering 
international trade is estimated to US 
$3 billion that générâtes a significant 
income for the economy of numerous 
LDCs. AH thèse facts and figures dem-
onstrate that banana isactually the most 
important fruit crop on earth. 
On the other hand, most cultivated 
bananas are parthenocarpic landraces 
that are stérile triploids. This and their 
relatively long life cycle hinders suc-
cessful hybridization programstotrans-
fer disease résistance from wild diploid 
sources. In addition, many landraces 
become susceptible to several viral, 
bacterial and fungal pathogens as well 
as the nematode and insect pests that 
cause steadily increasing problems in 
commercial plantations, too. For in-
stance, the annual cost of fungicide 
sprays against the pathogen of black 
Sigatoka leaf disease, Mycosphaerella 
fijiensis, ranges between US$600 and 
1800 per hectare which amounts up to 
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40% of the total production cost. Such 
sprayings are carried out almost every 
week and pose a high pressure to the 
environment as documented by the fré-
quent reported fish-kills in the neigh-
borhood of banana plantations. Highly 
toxic nematicides are also heavily used, 
some of which sterilized 13,000 planta-
tion workers in Costa Rica in the early 
1980s. Finally, smallholders and indi-
viduals who cannot afford or hâve ac-
cess to chemicals hâve to cope with 
yield déclines of 30% or more. 
While significant basic scientific 
knowledge is missing in many fields of 
banana research, important progress 
has been made recently in other areas 
(reviewed in réf. 3). For instance, no 
classical genetic maps are available, 
cytology and classical cytogenetics has 
been hardly done, and plant-pathogen 
interactions hâve been very poorly char-
acterized as well. On the other hand, 
banana is one of the most extensively 
micropropagated species in the world 
and various advanced in vitro culture 
techniques hâve been adapted for the 
production of regenerable embryogén-
ie cell suspension and protoplast cul-
tures. Based on this progress, foreign 
gènes were introduced into banana 
protoplasts and the first transgenic 
plants were produced either by particle 
bombardment of embryogénie cell sus-
pension cultures or by Agrobacterium-
mediated transformation of cultured 
meristems. While, due their sterility, 
most banana cultivars do not produce 
seeds under natural conditions and 
crosses with other cultivars or species 
will not occur, hère this handicap turns 
out to be an apparent advantage be-
cause the introduced transgene(s) 
remain(s) confined to the cultivar in 
which it has been introduced. Based on 
this argument banana can be consid-
ered as a low risk species for transgenic 
field trials as also confirmed by a the-
oretical model from différent viewpoints 
(4). 
FUNGAL DISEASE 
CONTROL BY GENETIC 
TRANSFORMATION 
Since the most significant damage as 
well as future threat to banana produc-
tion are caused by fungal pathogens, 
the introduction of gènes conferring 
résistance to thèse pathogens is a pri-
mary research target. Our efforts are 
presently focused on several gènes 
encoding stable, cysteine-rich antimi-
crobial peptides (AMPs) which are iso-
lated from seeds of diverse plant spe-
cies (reviewed in réf. 5). Thèse AMPs 
hâve a broad anti-fungal spectrum and 
show high in vitro activity against field 
isolâtes of Mycosphaerella fijiensis and 
Fusarium oxysporum, the two main 
fungal pathogens of banana, while they 
exert notoxicityto human or plant cells. 
To date, five AMP gènes hâve been 
introduced in our laboratory alone and 
in double- or triple combinations into 
embryogénie cell suspension cultures 
of banana using particle bombardment. 
Large-scale molecular and biochemical 
characterization of the regenerated 
transgenic lines confirmed that a vast 
majority contained and expressed the 
foreign gènes. For example, extensive 
PCR-screening of a total of 776 putative 
transgenic plants revealed that more 
than 90% of them contained the select-
able marker gène as well as the AMP 
gènes. Similarly, Southern hybridization 
of 56 independent transgenic plants 
demonstrated that 89.3% had the trans-
genes integrated in their génome. 
Tostudy the expression of antimicro-
bial peptides in the transgenic plants, 
some of the AMP gènes was placed 
under the control of three différent pro-
moters which had previously been 
shown to drive high gène expression in 
banana as well as in other monocots. 
Using spécifie antibodies, the concen-
tration of two AMPs in total transgenic 
leaf protein extracts ranged from 0.05% 
to more than 1% depending on the 
promoter used. Addition of thèse leaf 
extracts to germinating spores and 
mycelia of a field isolate of Mycosphaer-
ella fijiensis, the causal agent of black 
Sigatoka leaf disease, resulted in a sig-
nificant inhibition of fungal growth 
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making thèse plants likely candidates 
to control this pathogen under field 
conditions. In addition, screening of 
50 independent transgenic lines with a 
new in situ leaf bioassay allowed us to 
sélect and micropropagate lines with 
improved résistance to several fungal 
pathogens. 
Field tests will demonstrate whether 
thèse transgenic plants express the 
functional AMPs at levels high enough 
to control fungal leaf or root diseases in 
nature. It has been shown that one 
foreign AMP gène is also transcribed in 
the fruit, opening the opportunity to 
create résistance against pre- and post-
harvest diseases such as cigar-end rot 
and crown rot. 
INTRODUCTION OF 
TRANSGENIC PLANTS TO 
THIRD WORLD COUNTRIES: 
CONCERNS AND IMPACTS 
Once transgenic plants hâve been pro-
duced, their further management and 
field release requires the careful coor-
dination of a large number of factors. 
For instance, field release must be au-
thorized by national governments 
through their respective regulatory 
bodies. According to our expérience, 
field testing in thèse countries should 
definitely involve an active breeding 
program (such as a CGIAR institute) to 
ensure that plants are evaluated cor-
rectly and précise observations are tak-
en. However, in many LDCs operational 
regulatory bodies are not yet in place, 
and this causes delays in implementing 
field testing of transgenic plants. Addi-
tional delaying factors in many LDCs 
and especially in sub-Saharan Africa are: 
political instability, récent économie 
recession, lack of trained personnel 
(scientists, lawyers) devoted to clear 
confusion and suspicion and decrease 
bureaucracy. 
To date, no transgenic banana plants 
are being tested in the field. This is 
essentially due to the lack of functional 
regulatory bodies as well as to the 
underlying reasons in the countries 
where testing would be carried out. In 
view of the fact that more and more 
transgenic plants are being produced 
by laboratories Worldwide, the lack of 
regulatory mechanisms is likely to con-
tinue to be a major bottleneck to 
progress. It is therefore recommended 
that greater efforts, at both national and 
international level, be made to résolve 
this situation. 
Finally, in view of the limited resourc-
es being devoted to tropical crop re-
search, it is important that donor agen-
cies put emphasis on support ing 
collaboration between successful breed-
ing institutions and advanced biotech-
nology laboratories. However, for cor-
rect perception of the real situation, it 
may be interesting to know that the 
total plant biotechnology-related invest-
ment of CGIAR currently amounts to 
about US$15 million which is lessthan 
what a small biotechnology company 
spends on R&D in the United States (6). 
On the other hand, black Sigatoka résis-
tant bananas alone would produce at 
least US$6 billion added value if culti-
vated in sub-Saharan Africa only. 
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QUESTIONS 
What could be the optimal size of a 
transgenic field test for résistance to a 
single pathogen: e.g. number of trans-
genic and control lines, number of in-
dividuals per line, etc? 
How can efficient mechanisms be 
activated (esp. in the Third World) to 
change suspicion with transgenic plants 
and to accelerate légal procédures for 
the authorisation of field tests? 
Which stratégies can be adapted for 
using publicly acceptable target gènes 
and avoiding selectable marker gènes 
in vegetatively propagating plants? 
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